Australia's Illuccix receives approval for prostate cancer imaging in Brazil

Australia-based Telix Pharmaceuticals has announced that the Brazilian Health Regulatory Agency (Agencia Nacional d...

March 19, 2025 | Wednesday | News
ABL Diagnostics partners with Riken Genesis to expand microbiology genotyping in Japan

ABL Diagnostics, a Euronext-listed leader in molecular diagnostics, has announced an exclusive distribution agreement wi...

March 18, 2025 | Tuesday | News
Proteomics International launches predictive test for diabetic kidney disease in Australia

Proteomics International Laboratories, a pioneer in precision diagnostics, has announced the launch of its first...

March 18, 2025 | Tuesday | News
GE HealthCare expands invasive cardiology solutions portfolio with AltiX AI.i

American medtech firm GE HealthCare has announced the launch of the AltiX AI.i edition of Mac-Lab, CardioLab and ComboLa...

March 18, 2025 | Tuesday | News
Gene Bio Medical to manufacture high-quality diagnostic test kits for South Asian market

Gene Bio Medical (GBM), a leading Canadian biotechnology company specialising in molecular diagnostics, has signed a&nbs...

March 18, 2025 | Tuesday | News
AstraZeneca buys EsoBiotec for $1 B to advance cell therapy ambition

British pharmaceutical firm AstraZeneca has entered into a definitive agreement to acquire Belgium-based biotech startup...

March 17, 2025 | Monday | News
Teva enhances pharma distribution system in China

Teva Hong Kong has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network (KLN)....

March 14, 2025 | Friday | News
Shimadzu and DxD Hub establish joint lab to advance diagnostics innovation in Singapore

Shimadzu Corporation, a global leader in the precision instrumentation industry, and Diagnostics Development Hub (DxD Hu...

March 10, 2025 | Monday | News
Sheba Medical Center partners with Tethis to advance AI-powered liquid biopsy in rectal cancer

Italy-based Tethis S.p.A., a pioneer in standardised liquid biopsy platform development, and Sheba Medical Center, ...

March 10, 2025 | Monday | News
Indaptus Therapeutics extends patent portfolio in China, Japan, and Israel

US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its De...

March 7, 2025 | Friday | News
Lunit expands partnership with Saudi Arabia's largest medical group to deploy AI chest X-ray solution

South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnos...

March 7, 2025 | Friday | News
Astellas and Yaskawa to establish joint venture in Japan focused on cell therapy manufacturing

Japan-headquartered Astellas Pharma Inc. and Yaskawa Electric Corporation have signed a definitive agreement t...

March 6, 2025 | Thursday | News
SK Chemicals inks agreement with Viatris to expand pain management portfolio in Korea

SK Chemicals, which developed Korea's first herbal medicine product for osteoarthritis, Joins, has expanded its pai...

March 6, 2025 | Thursday | News
Antengene expands commercial presence in APAC with XPOVIO's approval in Indonesia for cancer treatment

China's oncology firm Antengene Corporation has announced that the Indonesia National Agency of Drug and Food Control (B...

March 6, 2025 | Thursday | News
Health2Sync secures over $20 M in Series C round, paving way for public listing in Taiwan market

Taiwan-based Health2Sync, a leading digital health company specialising in chronic disease management, has raised over $...

March 6, 2025 | Thursday | News
Boehringer Ingelheim enhances biopharmaceutical contract manufacturing services in China

Boehringer Ingelheim’s biopharmaceutical facility in Shanghai, China, meets the conditions to participate in a reg...

March 5, 2025 | Wednesday | News
Olympus to launch single-use hemostasis clip in US, with plans for global expansion

Japan-headquartered Olympus, a global medical technology company committed to making people's lives healthier, safer and...

March 5, 2025 | Wednesday | News
WuXi Biologics introduces new platform to boost recombinant protein and plasmid DNA production

China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...

March 4, 2025 | Tuesday | News